CPA
CORV

Columbia Pacific Advisors’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Columbia Pacific Advisors’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-130,709
Closed -$413K – 31
2019
Q1 		$413K Buy
130,709
+30,000
+30% +$97.1K 0.96% 18
2018
Q4 		$251K Buy
+100,709
New +$335K 0.52% 19

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Columbia Pacific Advisors's CORV Position: Q2 2019 in Review

Columbia Pacific Advisors sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2019, closing a stake of 130,709 shares — an estimated $413K sold.

Columbia Pacific Advisors first reported a position in CORV in Q4 2018 and held it in 2 quarters. The position peaked at $413K in Q1 2019. 36 funds tracked by Wall St. Rank hold CORV as of Q2 2019.

  • Columbia Pacific Advisors reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2019 after selling out during the quarter.
  • Columbia Pacific Advisors sold 130,709 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2019, an estimated $413K.
  • Columbia Pacific Advisors first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2018 and held it in 2 quarters.
  • Columbia Pacific Advisors's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $413K in Q1 2019.
  • 36 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2019.

Based on Columbia Pacific Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.